Written by The global Circrna Synthesis Market was valued at USD 217.54 million in 2025 and is projected to grow from USD 252.61 million in 2026 to USD 835.2 million by 2034, registering a robust CAGR of 16.12% during the forecast period.
The Circrna Synthesis Market is expanding rapidly due to increasing investments in RNA therapeutics, precision medicine, and next-generation vaccine development, supported by continuous innovations in circular RNA synthesis technologies.
Market Overview
The Circrna Synthesis Market is witnessing significant growth as biotechnology companies, pharmaceutical manufacturers, and research organizations increase their focus on advanced RNA technologies. Circular RNA offers greater molecular stability, prolonged protein expression, and enhanced resistance to degradation compared to conventional linear RNA, making it highly attractive for therapeutic applications. Rising demand for customized synthesis services, specialized reagents, purification technologies, and automated production platforms continues to strengthen industry expansion. Increased investments in oncology research, rare disease therapies, regenerative medicine, and infectious disease prevention are further supporting market development. Continuous advancements in RNA engineering and manufacturing technologies are expected to create substantial commercial opportunities throughout the forecast period.
Market Insights
The market continues to benefit from increasing funding for genomic research and RNA-based drug discovery worldwide. Pharmaceutical and biotechnology companies remain the leading end users as they expand research programs focused on cancer immunotherapy, neurological disorders, cardiovascular diseases, and personalized medicine. Improved enzymatic circularization methods, advanced analytical platforms, and scalable manufacturing capabilities are enabling higher production efficiency and product quality. Growing collaboration between academic institutions, contract research organizations, and commercial developers is accelerating innovation while supporting faster clinical development and commercialization of circRNA-based therapies.
Market Trends
Growing adoption of artificial intelligence, bioinformatics platforms, and automated RNA design technologies is transforming circRNA development. Companies are introducing innovative reagents, purification systems, and custom synthesis services that improve workflow efficiency and product consistency. Increasing demand for GMP-compliant manufacturing facilities and high-purity synthetic circRNA products is supporting commercialization efforts across therapeutic development and drug discovery. Strategic collaborations between biotechnology firms and research institutes continue to drive innovation, while expanding applications in oncology, vaccines, regenerative medicine, and precision therapeutics are strengthening future market potential.
For detailed market insights, visit the Circrna Synthesis Market reports: https://www.fortunebusinessinsights.com/circrna-synthesis-market-117527
Market Growth Factors
The primary growth factor is the increasing demand for RNA-based therapeutics and advanced vaccine platforms. Circular RNA enables durable protein expression and enhanced biological stability, making it an attractive solution for next-generation medical applications. Expanding investments in biotechnology infrastructure, precision medicine, and genomic research continue to increase demand for synthesis reagents, instruments, and custom services. Ongoing improvements in enzymatic circularization, RNA purification, automation, and quality control technologies are enhancing commercial feasibility. Although manufacturing complexity and scalability remain challenges, continuous technological innovation and growing research funding are expected to sustain long-term market growth.
Competitor Analysis
The competitive landscape includes leading biotechnology companies focused on innovation, strategic partnerships, and product development. Major participants include GenScript, LGC Biosearch Technologies, Creative Biogene, SBS Genetech, Applied Biological Materials Inc., Amerigo Scientific, GeneCopoeia, BOC Sciences, Guangzhou Geneseed Biotech. Co., Ltd., and Creative Biolabs. GenScript leads the market with approximately 16% share, followed by LGC Biosearch Technologies with around 13%. Companies are expanding manufacturing capacity, introducing advanced synthesis solutions, and investing heavily in RNA engineering technologies to strengthen their competitive position and support increasing global demand.
Segmentation Analysis
Based on product and service, reagents and kits dominate the market with nearly 47% share owing to recurring demand across research laboratories and pharmaceutical companies. Instruments account for approximately 22%, supported by increasing adoption of automated synthesis and analytical systems, while services contribute around 31% through customized synthesis, purification, and validation offerings. By application, therapeutics development represents nearly 64% of total demand due to growing clinical research in oncology, rare diseases, and vaccine development, whereas drug discovery contributes about 36%. Pharmaceutical and biotechnology companies collectively account for nearly 60% of total end-user demand, reflecting strong commercial investment in RNA technologies.
Regional Insights
North America dominates the global market with approximately 46% share, supported by advanced biotechnology infrastructure, strong clinical research capabilities, and significant investments in RNA therapeutics led by the United States. Europe accounts for around 27%, driven by active research programs and expanding biotechnology industries across Germany, the United Kingdom, France, and the Netherlands. Asia-Pacific holds nearly 21% and represents the fastest-growing regional market due to increasing biotechnology investments, expanding healthcare infrastructure, and strong government support in China, Japan, South Korea, and Singapore. Emerging markets across Latin America, the Middle East, and Africa continue to enhance research capabilities through international collaborations and healthcare investments, creating additional long-term growth opportunities.
For request sample reports: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/circrna-synthesis-market-117527
ABOUT:
Fortune Business InsightsTM provides strategic corporate analysis and precise data, assisting organizations of all sizes promptly to make well-informed decisions. Our reports combine comprehensive market studies enriched with relevant data crafted by our seasoned analysts and consultants utilizing industry-leading research tools and methodologies. To this end, we offer services that are designed to help organizations uncover hidden opportunities and comprehend existing competitive challenges.
Contact Us:
Fortune Business InsightsTM Pvt. Ltd.
Phone:
U.S.: US +1 833 909 2966 (Toll Free)
UK +44 808 502 0280 (Toll Free)
APAC +91 744 740 1245
Email: sales@fortunebusinessinsights.com